LITYNDA Trademark

Trademark Overview

On Friday, March 5, 2010, a trademark application was filed for LITYNDA with the United States Patent and Trademark Office. The USPTO has given the LITYNDA trademark a serial number of 77951421. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 21, 2013. This trademark is owned by Novartis AG. The LITYNDA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antibiotics; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes
litynda

General Information

Serial Number77951421
Word MarkLITYNDA
Filing DateFriday, March 5, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 21, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 27, 2010

Trademark Statements

Goods and ServicesAnti-infectives; Antibiotics; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 21, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, October 21, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 21, 2013ABANDONMENT - NO USE STATEMENT FILED
Monday, July 1, 2013ASSIGNED TO EXAMINER
Friday, March 15, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 14, 2013EXTENSION 5 GRANTED
Monday, March 11, 2013EXTENSION 5 FILED
Monday, March 11, 2013TEAS EXTENSION RECEIVED
Tuesday, September 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 24, 2012EXTENSION 4 GRANTED
Tuesday, September 18, 2012EXTENSION 4 FILED
Tuesday, September 18, 2012TEAS EXTENSION RECEIVED
Tuesday, March 13, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 12, 2012EXTENSION 3 GRANTED
Friday, March 9, 2012EXTENSION 3 FILED
Friday, March 9, 2012TEAS EXTENSION RECEIVED
Friday, September 16, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 15, 2011EXTENSION 2 GRANTED
Tuesday, September 13, 2011EXTENSION 2 FILED
Thursday, September 15, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 13, 2011TEAS EXTENSION RECEIVED
Wednesday, March 23, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2011EXTENSION 1 GRANTED
Monday, March 21, 2011EXTENSION 1 FILED
Monday, March 21, 2011TEAS EXTENSION RECEIVED
Tuesday, September 21, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 27, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 27, 2010PUBLISHED FOR OPPOSITION
Monday, June 21, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 21, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 18, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 18, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 18, 2010ASSIGNED TO LIE
Monday, June 7, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 4, 2010NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, June 4, 2010EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, June 4, 2010EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Friday, June 4, 2010REMOVED FROM TEAS PLUS
Wednesday, June 2, 2010ASSIGNED TO EXAMINER
Wednesday, March 10, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 9, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

litynda disorders system diseases treatment preparations prevention pharmaceutical oncology ophthalmology hematology